• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血液的蛋白生物标志物与阿尔茨海默病连续体中的脑 MRI 的关联:系统评价。

Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review.

机构信息

Department of Medicine and Surgery, University of Parma, Parma, Italy.

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

出版信息

J Neurol. 2024 Nov;271(11):7120-7140. doi: 10.1007/s00415-024-12674-w. Epub 2024 Sep 12.

DOI:10.1007/s00415-024-12674-w
PMID:39264441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11560990/
Abstract

Blood-based biomarkers (BBM) are becoming easily detectable tools to reveal pathological changes in Alzheimer's disease (AD). A comprehensive and up-to-date overview of the association between BBM and brain MRI parameters is not available. This systematic review aimed to summarize the literature on the associations between the main BBM and MRI markers across the clinical AD continuum. A systematic literature search was carried out on PubMed and Web of Science and a total of 33 articles were included. Hippocampal volume was positively correlated with Aβ42 and Aβ42/Aβ40 and negatively with Aβ40 plasma levels. P-tau181 and p-tau217 concentrations were negatively correlated with temporal grey matter volume and cortical thickness. NfL levels were negatively correlated with white matter microstructural integrity, whereas GFAP levels were positively correlated with myo-inositol values in the posterior cingulate cortex/precuneus. These findings highlight consistent associations between various BBM and brain MRI markers even in the pre-clinical and prodromal stages of AD. This suggests a possible advantage in combining multiple AD-related markers to improve accuracy of early diagnosis, prognosis, progression monitoring and treatment response.

摘要

基于血液的生物标志物 (BBM) 正成为揭示阿尔茨海默病 (AD) 病理变化的便捷检测工具。目前尚无关于 BBM 与脑 MRI 参数之间关联的全面、最新综述。本系统评价旨在总结主要 BBM 与 MRI 标志物在 AD 临床连续体中相关性的文献。在 PubMed 和 Web of Science 上进行了系统的文献检索,共纳入 33 篇文章。海马体积与 Aβ42 和 Aβ42/Aβ40 呈正相关,与 Aβ40 血浆水平呈负相关。p-tau181 和 p-tau217 浓度与颞叶灰质体积和皮质厚度呈负相关。NfL 水平与白质微观结构完整性呈负相关,而 GFAP 水平与后扣带回/楔前叶肌醇值呈正相关。这些发现强调了各种 BBM 与脑 MRI 标志物之间的一致关联,即使在 AD 的临床前和前驱期也是如此。这表明,联合使用多种 AD 相关标志物可能具有优势,有助于提高早期诊断、预后、进展监测和治疗反应的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5649/11560990/9f9385a384cf/415_2024_12674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5649/11560990/9f9385a384cf/415_2024_12674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5649/11560990/9f9385a384cf/415_2024_12674_Fig1_HTML.jpg

相似文献

1
Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review.基于血液的蛋白生物标志物与阿尔茨海默病连续体中的脑 MRI 的关联:系统评价。
J Neurol. 2024 Nov;271(11):7120-7140. doi: 10.1007/s00415-024-12674-w. Epub 2024 Sep 12.
2
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
3
Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study.社区动脉粥样硬化风险研究中阿尔茨海默病和神经退行性变的嗅觉与血浆生物标志物
Neurology. 2025 Jun 10;104(11):e213706. doi: 10.1212/WNL.0000000000213706. Epub 2025 May 15.
4
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.利用血浆生物标志物预测唐氏综合征患者的淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究。
Lancet Neurol. 2025 Jul;24(7):591-600. doi: 10.1016/S1474-4422(25)00158-9.
5
Short-term variability of Alzheimer's disease plasma biomarkers in a mixed memory clinic cohort.混合记忆门诊队列中阿尔茨海默病血浆生物标志物的短期变异性
Alzheimers Res Ther. 2025 Jan 21;17(1):26. doi: 10.1186/s13195-024-01658-7.
6
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.血浆Aβ42/40比值、磷酸化tau181、胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)在阿尔茨海默病和非阿尔茨海默病性痴呆连续病程中的诊断性能:一项国际多中心研究
Alzheimers Dement. 2025 Jun;21(6):e14573. doi: 10.1002/alz.14573.
7
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum.唐氏综合征中沿阿尔茨海默病连续谱的内侧颞叶萎缩
Brain. 2025 Apr 17. doi: 10.1093/brain/awaf133.
8
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum.血浆磷酸化tau217与阿尔茨海默病谱系中的记忆缺陷密切相关。
Brain. 2025 Jan 29. doi: 10.1093/brain/awaf033.
9
Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity.糖尿病与超重或肥胖个体中的阿尔茨海默病血液生物标志物与认知
JAMA Netw Open. 2025 Feb 3;8(2):e2458149. doi: 10.1001/jamanetworkopen.2024.58149.
10
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.

本文引用的文献

1
Neuroimaging modalities in the detection of Alzheimer's disease-associated biomarkers.用于检测阿尔茨海默病相关生物标志物的神经成像模态
Psychoradiology. 2023 Jun 22;3:kkad009. doi: 10.1093/psyrad/kkad009. eCollection 2023.
2
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.血浆 p-tau231 和 p-tau217 可反映认知障碍个体中 tau 缠结的聚集情况。
Alzheimers Dement. 2023 Oct;19(10):4463-4474. doi: 10.1002/alz.13393. Epub 2023 Aug 3.
3
Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China.
基于血液的阿尔茨海默病生物标志物:中国多中心的横断面和纵向研究。
Sci Bull (Beijing). 2023 Aug 30;68(16):1800-1808. doi: 10.1016/j.scib.2023.07.009. Epub 2023 Jul 10.
4
GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis.胶质纤维酸性蛋白(GFAP)作为阿尔茨海默病的潜在生物标志物:系统评价和荟萃分析。
Cells. 2023 May 4;12(9):1309. doi: 10.3390/cells12091309.
5
Plasma phosphorylated tau 217 in preclinical Alzheimer's disease.临床前阿尔茨海默病中的血浆磷酸化tau 217
Brain Commun. 2023 Mar 6;5(2):fcad057. doi: 10.1093/braincomms/fcad057. eCollection 2023.
6
Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic.阿尔茨海默病的血浆生物标志物:记忆诊所的现场测试。
J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):420-427. doi: 10.1136/jnnp-2022-330619. Epub 2023 Apr 3.
7
Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.探究主观认知衰退的老年人群的代偿性脑活动。
J Alzheimers Dis. 2023;93(1):107-124. doi: 10.3233/JAD-221001.
8
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.阿尔茨海默病患者血浆中的磷酸化tau:朝着诊断和治疗试验应用的方向发展。
Mol Neurodegener. 2023 Mar 16;18(1):18. doi: 10.1186/s13024-023-00605-8.
9
Plasma biomarkers for neurodegenerative disorders: ready for prime time?用于神经退行性疾病的血浆生物标志物:是否已准备好投入使用?
Curr Opin Psychiatry. 2023 Mar 1;36(2):112-118. doi: 10.1097/YCO.0000000000000851. Epub 2023 Jan 16.
10
Altered functional connectivity pattern of hippocampal subfields in individuals with objectively-defined subtle cognitive decline and its association with cognition and cerebrospinal fluid biomarkers.客观定义的轻度认知衰退个体中海马亚区功能连接模式的改变及其与认知和脑脊液生物标志物的关系。
Eur J Neurosci. 2022 Dec;56(12):6227-6238. doi: 10.1111/ejn.15860. Epub 2022 Nov 22.